Corcept Therapeutics (CORT) Gross Margin Growth (3y) (2015 - 2026)

Corcept Therapeutics (CORT) Gross Margin Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 722.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -162.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Corcept Therapeutics 9.56 Bn 9.22 Bn 162.02 Mn -44.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -44.00
Dec 31, 2025 18.00
Sep 30, 2025 -90.00
Jun 30, 2025 -49.00
Mar 31, 2025 -19.00
Dec 31, 2024 -26.00
Sep 30, 2024 -24.00
Jun 30, 2024 -3.00
Mar 31, 2024 -13.00
Dec 31, 2023 8.00
Sep 30, 2023 8.00
Jun 30, 2023 6.00
Mar 31, 2023 70.00
Dec 31, 2022 20.00
Sep 30, 2022 46.00
Jun 30, 2022 63.00
Mar 31, 2022 58.00
Dec 31, 2021 99.00
Sep 30, 2021 70.00
Jun 30, 2021 34.00